))
Chatter with BNC | Kevin O'Brien, President of Merz Therapeutics
Manage episode 404903206 series 3004501
Indhold leveret af Business North Carolina. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Business North Carolina eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Welcome to Chatter with BNC, Business North Carolina's weekly podcast, serving up interviews with some of the Tar Heel State's most interesting people. Today's episode features an interview with Kevin O’Brien. O'Brien serves as president of North America for Merz Therapeutics, where he leads commercial strategy and execution, including field sales, managed markets, medical affairs, marketing and operations, across the U.S. and Canada. Since joining Merz in 2017, he has overseen the U.S. FDA approval of Merz’s neuromodulator for the treatment of sialorrhea (excessive drooling) and as a first-line treatment for blepharospasm, two debilitating conditions associated with neurological conditions, including Parkinson’s disease, ALS and cerebral palsy.
…
continue reading
101 episoder
Del
